CPRX

Catalyst Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$24.69

Market Cap

$3.03B

Beta

0.66

P/E

15.3

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+19.78%

EPS Growth (YoY)+28.24%

Revenue CAGR 3Y+40.10%

P/E Ratio15.3

PEG Ratio0.52

FCF Yield+6.87%

Debt / Equity0.00

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for CPRX.